日本一女性疑感染埃博拉出血热,安倍下令加强防疫

2019-08-04 佚名 中新网

据“中央社”报道,当地时间4日,日本厚生劳动省表示,一名从非洲中部刚果(金)返回日本的70多岁妇女,疑似感染埃博拉病毒出血热。日本首相安倍晋三已下令有关单位要做好治疗、检疫工作。日本厚生劳动省表示,7月31日从刚果(金)返回日本、家住埼玉县的一名70多岁妇女因为发烧就医,后来被医师诊断疑似罹患埃博拉病毒出血热。目前她正在国立感染病研究所村山厅舍(位于东京都武藏村山市)接受检查。据报道,为应对此事,

据“中央社”报道,当地时间4日,日本厚生劳动省表示,一名从非洲中部刚果(金)返回日本的70多岁妇女,疑似感染埃博拉病毒出血热。日本首相安倍晋三已下令有关单位要做好治疗、检疫工作。

日本厚生劳动省表示,7月31日从刚果(金)返回日本、家住埼玉县的一名70多岁妇女因为发烧就医,后来被医师诊断疑似罹患埃博拉病毒出血热。目前她正在国立感染病研究所村山厅舍(位于东京都武藏村山市)接受检查。

据报道,为应对此事,日本首相官邸(行政中心)危机管理中心设置信息联络室,日本首相安倍晋三下令相关单位医治这名妇女,并落实检疫工作。

报道称,这名妇女表示,他在刚果(金)并没与埃博拉出血热患者接触过。

日本厚生劳动省表示,这名女性因工作的关系,至少8个月前就在刚果(金),7月31日返回日本,在检疫所接受2次体温检查。3日清晨她出现发高烧的情况,住进东京都一所医疗院所接受诊察,被医师诊断出有A型流感。

报道称,刚果(金)东部持续有埃博拉病毒出血热疫情,世界卫生组织(WHO)7月17日宣布,刚果(金)埃博拉病毒感染疫情为国际关注公共卫生紧急事件。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1294490, encodeId=e6c012944901c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402576, encodeId=a21114025e685, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569512, encodeId=1f681569512f6, content=<a href='/topic/show?id=4bd6314e0f2' target=_blank style='color:#2F92EE;'>#出血热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31470, encryptionId=4bd6314e0f2, topicName=出血热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1a815510226, createdName=qilu_qi, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623055, encodeId=099a16230552d, content=<a href='/topic/show?id=562a4155249' target=_blank style='color:#2F92EE;'>#埃博拉出血热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41552, encryptionId=562a4155249, topicName=埃博拉出血热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459120466623, createdName=huanbaofeng, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1294490, encodeId=e6c012944901c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402576, encodeId=a21114025e685, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569512, encodeId=1f681569512f6, content=<a href='/topic/show?id=4bd6314e0f2' target=_blank style='color:#2F92EE;'>#出血热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31470, encryptionId=4bd6314e0f2, topicName=出血热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1a815510226, createdName=qilu_qi, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623055, encodeId=099a16230552d, content=<a href='/topic/show?id=562a4155249' target=_blank style='color:#2F92EE;'>#埃博拉出血热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41552, encryptionId=562a4155249, topicName=埃博拉出血热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459120466623, createdName=huanbaofeng, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1294490, encodeId=e6c012944901c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402576, encodeId=a21114025e685, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569512, encodeId=1f681569512f6, content=<a href='/topic/show?id=4bd6314e0f2' target=_blank style='color:#2F92EE;'>#出血热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31470, encryptionId=4bd6314e0f2, topicName=出血热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1a815510226, createdName=qilu_qi, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623055, encodeId=099a16230552d, content=<a href='/topic/show?id=562a4155249' target=_blank style='color:#2F92EE;'>#埃博拉出血热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41552, encryptionId=562a4155249, topicName=埃博拉出血热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459120466623, createdName=huanbaofeng, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]
    2019-08-06 qilu_qi
  4. [GetPortalCommentsPageByObjectIdResponse(id=1294490, encodeId=e6c012944901c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402576, encodeId=a21114025e685, content=<a href='/topic/show?id=546f9e45197' target=_blank style='color:#2F92EE;'>#防疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97451, encryptionId=546f9e45197, topicName=防疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf7e2418349, createdName=zhangying8789, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569512, encodeId=1f681569512f6, content=<a href='/topic/show?id=4bd6314e0f2' target=_blank style='color:#2F92EE;'>#出血热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31470, encryptionId=4bd6314e0f2, topicName=出血热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1a815510226, createdName=qilu_qi, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623055, encodeId=099a16230552d, content=<a href='/topic/show?id=562a4155249' target=_blank style='color:#2F92EE;'>#埃博拉出血热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41552, encryptionId=562a4155249, topicName=埃博拉出血热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459120466623, createdName=huanbaofeng, createdTime=Tue Aug 06 12:24:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]

相关资讯

经骶髂关节开窗入路清除骶骨异物残留伴感染1例

患者,男,33岁,于2012-03不慎从3m的高处坠落下来,并被竖在地面的1根钢管从肛门左侧刺入盆腔,急诊到当地医院拔出钢管、清洗创道,此后创口持续渗液不愈合。曾先后4次经盆腔行病灶清创术,未获得愈合。入院查体:下腹部正中见纵形切口瘢痕,愈合好。距肛门2CM、11点钟方向见窦道,流出脓性液体。双下肢感觉运动正常,会阴部及肛门括约肌感觉运动正常。影像学检查:经窦道造影显示造影剂流注到骶骨前侧;CT扫

Intensive Care Med:脓毒性海绵窦血栓形成1例

54岁,男性,因左侧眼痛几周就诊。

AMR中心和日本Shionogi合作开发COT-143单抗,治疗铜绿假单胞菌感染

AMR中心宣布与日本制药公司Shionogi达成一项具有里程碑意义的协议,以推进其抗菌药物COT-143。COT-143是一种新型人源化单克隆抗体,旨在帮助身体应对铜绿假单胞菌感染,这是一种难以治疗的耐药病原体,世界卫生组织(WHO)认定其为人类健康的重大威胁。

播散性鸟分枝杆菌感染1 例

患者女, 37 岁。咳嗽、咳痰伴发热 2 + 年,颈胸 部、四肢结节、溃疡1 年。2 年前患者出现咳嗽伴咳 痰,不规律发热,于当地医院查痰抗酸染色阳性,诊 断肺结核。先后给予异烟肼、利福平、吡嗪酰胺、乙 胺丁醇,异烟肼、利福平、乙胺丁醇抗痨治疗。1 年 前患者颈部多发皮下结节,轻度疼痛,之后下颌处、 躯干、膝部、手指相继出现多发皮下结节,局部逐渐 破溃、溢脓。曾多次于院外行分泌物微生物检查提 示“

JAMA:CSF非培养感染检测在免疫功能正常的儿童中很常见,但阳性结果很少

脑脊液(CSF)非培养感染检测对免疫能力正常且细胞计数正常的儿童有何价值?这项横断面研究调查了一家大型学术性三级护理儿童医院的电子病历系统中的筛选和诊断检测,回顾了2007年7月1日至2016年12月31日在医院住院或门诊进行腰椎穿刺(4811次手术)的0.5岁至18.9岁儿童的记录。有留置的CSF分流器或导管的患者、现患有或有病史的肿瘤、免疫或风湿病的患者、服用免疫抑制药物的患者被排除。4083

JCLA:重组链霉亲和蛋白融合蛋白作为快速检测丙型肝炎病毒感染的信号转导蛋白

丙型肝炎病毒(HCV)感染得早期诊断对该病的治疗非常重要。因此,研制灵敏、特异的快速检测方法对该病的诊断也具有重要意义。在这里,我们描述了一种很有前景的方法,使用金‐标记的链霉亲和蛋白融合蛋白作为新的信号报告蛋白,用于快速检测丙型肝炎病毒感染。 在表达载体pMAL‐5CX和pET28中克隆了与大肠杆菌麦芽糖结合蛋白(MBP)或部分细菌翻译起始因子2融合的链霉亲和素重组基因,并在适当的大肠杆菌